Introduction

We continue our reports from the 11th International Workshop on Adverse Drug Reactions 
and Co-morbidities in HIV
, held this year from 26–28 October 2009 in Philadelphia, with this report on important new research for hepatitis C treatment.

• The HCV pipeline – efficacy and side effects of compounds in Phase 3 studies

The meeting organisers make nearly all oral presentations to be available as free access webcasts. The oral plenary lectures at the meeting are of a consistently high standard, often inviting experts from outside the HIV field to provide an overview on newly emerging issues relating to long-term HIV management.

http://lipo09.events-register.com